KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Shares Issued (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Shares Issued for 10 consecutive years, with $22.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 1706.76% year-over-year to $22.7 million, compared with a TTM value of $57.0 million through Dec 2025, up 259.45%, and an annual FY2025 reading of $57.0 million, up 259.45% over the prior year.
  • Shares Issued was $22.7 million for Q4 2025 at Medpace Holdings, up from $8.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $25.9 million in Q1 2025 and bottomed at $351000.0 in Q2 2025.
  • Average Shares Issued over 5 years is $6.2 million, with a median of $3.8 million recorded in 2021.
  • The sharpest move saw Shares Issued plummeted 85.07% in 2021, then soared 1706.76% in 2025.
  • Year by year, Shares Issued stood at $2.4 million in 2021, then soared by 136.98% to $5.8 million in 2022, then crashed by 73.56% to $1.5 million in 2023, then dropped by 17.4% to $1.3 million in 2024, then skyrocketed by 1706.76% to $22.7 million in 2025.
  • Business Quant data shows Shares Issued for MEDP at $22.7 million in Q4 2025, $8.0 million in Q3 2025, and $351000.0 in Q2 2025.